The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

N••••••

Healthcare & Pharmaceuticalsgroup grade Bon a schedule nowsponsor unattributed
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q2 2025: 101¢Q3 2025: 101¢Q4 2025: 100¢Q1 2026: 100¢Q2 2026: 100¢101¢ · 101¢ · 100¢ · 100¢ · 100¢Q2 2025 to Q2 2026
Principal held
at least $1.6M
sum of BDC pieces, a lower bound
Fair value
$1.5M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Dec 31, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2023
latest Jun 30, 2026
Events
4
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
LenderExposureCurrent markQoQ change
A•••• C••••• B•• I•••$1.57M100¢0 pts
Every BDC piece · 6 positions across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$1.2M$1.2M
100c
SOFR+550 bp
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$239,659$235,465
99c
SOFR+550 bp
A•••• C••••• B•• I•••revolver first lien
Investment T••• 1st L••• R••••••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D••
$85,071$83,582
98c
SOFR+550 bp
A•••• C••••• B•• I•••delayed draw term loan first lien
Investment T••• 1st L••• D••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% M••••••• 12/31/202
Not disclosedNot disclosedSOFR+550 bp
A•••• C••••• B•• I•••revolver first lien
Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.18% M•
Not disclosedNot disclosedSOFR+550 bp
View all 6 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
A•••• C••••• B•• I•••delayed draw term loan first lien
Investment T••• 1st L••• D••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% M••••••• 12/31/202
Not disclosedNot disclosedSOFR+550 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $1.5M100cSOFR+550 bpDec 31, 20281
first lien revolver first lienat least $85,071n/aSOFR+550 bpDec 31, 20281
first lien delayed draw term loan first lienunknownn/aSOFR+550 bpDec 31, 20281
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$1.6M$1.5M100c0
Mar 31, 20261$736,138$727,146100c0
Dec 31, 20251$1.6M$1.5M100c0
Sep 30, 20251$1.5M$1.5M101c0
All 8 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20251$1.5M$1.5M101c0
Mar 31, 20251$1.5M$1.5M102c0
Dec 31, 20241$3.0M$3.0M102c0
Dec 31, 20231$0$0n/a0
What changed
Full timeline · 6 events
Every change including routine ones
Identity
Group key
NVISIONderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Healthcare & Pharmaceuticalsreportedas one filer wrote it